top
Search terms
Results 1 - 10 of 37 - ordered by :
Pages: 1 2 3 4
Ejhf

Microvolt T‐wave alternans testing should be used to guide arrhythmic therapy in heart failure patients [1] reported on a cohort of heart failure patients and concluded that microvolt T-wave ...

European Journal of Heart Failure, Hohnloser, Stefan H., Cohen, Richard J.

Date : 01/06/2012 Item size : 56543 bytes
Ejhf

Microvolt T‐wave alternans testing should be used to guide arrhythmic therapy in heart failure patients [1] reported on a cohort of heart failure patients and concluded that microvolt T-wave ...

European Journal of Heart Failure, Hohnloser, Stefan H., Cohen, Richard J.

Date : 01/06/2012 Item size : 56589 bytes
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147574 bytes
Ehjournal

Vitamin K antagonists such as warfarin are highly effective for the prevention of stroke and systemic embolism in patients with AF,1 but their use is hampered by multiple food and drug interactions, ...

European Heart Journal, Hohnloser, Stefan H., Eikelboom, John W.

Date : 01/08/2012
Ehjournal

In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. Methods and results We ...

European Heart Journal, Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.

Date : 01/07/2010
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147532 bytes
Ehjournal

Abstract Aims The aim of this study was to evaluate the effects of apixaban, a novel oral factor Xa inhibitor, on the need for cardiovascular hospitalization. Methods and results Our analysis is ...

European Heart Journal, Hohnloser, Stefan H., Shestakovska, Olga, Eikelboom, John, Franzosi, Maria Grazia, Tan, Ru San, Zhu, Jun, Yusuf, Salim, Connolly, Stuart J.

Date : 14/09/2013 Item size : 209869 bytes
Ehjournal

Conclusion In a large population of non-anticoagulated AF patients, pattern of AF was a strong independent predictor of stroke risk and may be helpful to assess the risk/benefit for anticoagulant ...

European Heart Journal, Vanassche, Thomas, Lauw, Mandy N., Eikelboom, John W., Healey, Jeff S., Hart, Robert G., Alings, Marco, Avezum, Alvaro, Díaz, Rafael, Hohnloser, Stefan H., Lewis, Basil S., ...

Date : 01/02/2015 Item size : 328635 bytes
Ehjournal

In the second of a two-part review, we discuss the use of NOAC for stroke prevention in the following subgroups of patients with AF: (vii) secondary stroke prevention in patients after stroke or ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017 Item size : 483367 bytes